Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.
Voo KS, Foglietta M, Percivalle E, Chu F, Nattamai D, Harline M, Lee ST, Bover L, Lin HY, Baladandayuthapani V, Delgado D, Luong A, Davis RE, Kwak LW, Liu YJ, Neelapu SS. Voo KS, et al. Among authors: lee st. Int J Cancer. 2014 Dec 15;135(12):2834-46. doi: 10.1002/ijc.28937. Epub 2014 May 12. Int J Cancer. 2014. PMID: 24771328 Free PMC article.
Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW. Neelapu SS, et al. Among authors: lee st. Expert Rev Vaccines. 2006 Jun;5(3):381-94. doi: 10.1586/14760584.5.3.381. Expert Rev Vaccines. 2006. PMID: 16827622 Free article. Review.
Therapeutic vaccine for lymphoma.
Lee ST, Neelapu SS, Kwak LW. Lee ST, et al. Yonsei Med J. 2007 Feb 28;48(1):1-10. doi: 10.3349/ymj.2007.48.1.1. Yonsei Med J. 2007. PMID: 17326239 Free PMC article. Review.
Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma.
Strati P, Lee ST, Teegavarupu P, Karri A, Anireddy S, Hagemeister FB, Romaguera J, Fayad LE, Rodriguez MA, Samaniego F, Fowler N, Westin J, Wang M, Lee HJ, Pinnix C, Gunther JR, Dabaja B, Feng L, Davis RE, Neelapu SS. Strati P, et al. Among authors: lee st, lee hj. Am J Hematol. 2019 Jun;94(6):E150-E153. doi: 10.1002/ajh.25447. Epub 2019 Mar 6. Am J Hematol. 2019. PMID: 30785215 Free article. No abstract available.
A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Ribrag V, Lee ST, Rizzieri D, Dyer MJS, Fayad L, Kurzrock R, Andritsos L, Bouabdallah R, Hayat A, Bacon L, Jiang Y, Miah K, Delafont B, Hamid O, Anyanwu S, Martinez P, Hess B. Ribrag V, et al. Among authors: lee st. Clin Lymphoma Myeloma Leuk. 2021 May;21(5):309-317.e3. doi: 10.1016/j.clml.2020.12.012. Epub 2020 Dec 17. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33632668 Free article. Clinical Trial.
Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma.
Lutfi F, Holtzman N, Siglin J, Bukhari A, Mustafa Ali M, Kim D, Sanchez-Petitto G, Gottlieb D, Ruehle K, Hutnick E, Gahres N, Hankey K, Lee S, Kocoglu M, Yared J, Hardy N, Rapoport A, Dahiya S. Lutfi F, et al. Br J Haematol. 2021 Jan;192(1):212-216. doi: 10.1111/bjh.17121. Epub 2020 Nov 10. Br J Haematol. 2021. PMID: 33169845 Free article. No abstract available.
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
Lutfi F, Holtzman NG, Kansagra AJ, Mustafa Ali M, Bukhari A, Yan J, Samanta S, Gottlieb D, Kim DW, Matsumoto LR, Gahres N, Ruehle K, Lee ST, Law JY, Kocoglu MH, Atanackovic D, Yared JA, Hardy NM, Molitoris J, Mohindra P, Rapoport AP, Dahiya S. Lutfi F, et al. Among authors: lee st. Br J Haematol. 2021 Nov;195(3):405-412. doi: 10.1111/bjh.17738. Epub 2021 Sep 9. Br J Haematol. 2021. PMID: 34500492
2,369 results